| Q-o-Q | REVENUES | OPERATING PROFIT | PROFIT AFTER TAX | EPS | Updated : 20-Sep-21 | Details👇 |
| Consolidated | Jun2021 UnAudited |
Mar2021 Audited |
Dec2020 UnAudited |
Sep2020 UnAudited |
Jun2020 UnAudited |
Mar2020 Audited |
Dec2019 UnAudited |
Sep2019 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹4,025 Cr | ₹3,847 Cr | ₹3,796 Cr | ₹3,820 Cr | ₹3,515 Cr | ₹3,752 Cr | ₹3,638 Cr | ₹3,367 Cr |
| Expenses | ₹3,092 Cr | ₹2,991 Cr | ₹2,989 Cr | ₹2,957 Cr | ₹2,724 Cr | ₹2,961 Cr | ₹2,940 Cr | ₹2,731 Cr |
| Operating Income | ₹933 Cr | ₹855 Cr | ₹807 Cr | ₹863 Cr | ₹791 Cr | ₹791 Cr | ₹698 Cr | ₹636 Cr |
| Other Income | ₹32 Cr | ₹-40 Cr | ₹28 Cr | ₹28 Cr | ₹23 Cr | ₹44 Cr | ₹20 Cr | ₹27 Cr |
| Interest | ₹27 Cr | ₹23 Cr | ₹27 Cr | ₹46 Cr | ₹68 Cr | ₹83 Cr | ₹81 Cr | ₹90 Cr |
| Depreciation | ₹183 Cr | ₹189 Cr | ₹180 Cr | ₹179 Cr | ₹173 Cr | ₹179 Cr | ₹174 Cr | ₹172 Cr |
| Profit Before Tax | ₹755 Cr | ₹530 Cr | ₹627 Cr | ₹534 Cr | ₹573 Cr | ₹522 Cr | ₹457 Cr | ₹122 Cr |
| Profit After Tax | ₹613 Cr | ₹732 Cr | ₹513 Cr | ₹424 Cr | ₹454 Cr | ₹414 Cr | ₹364 Cr | ₹83 Cr |
| EPS | ₹5.73 | ₹6.63 | ₹5.15 | ₹4.62 | ₹4.43 | ₹3.83 | ₹3.65 | ₹1.05 |
| Peers & Returns | 1W | 1M | 1Y |
| CADILA HEALTHCARE | 1.6% | 3.3% | 37.2% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.1% | -0.3% | 47.1% |
| DIVIS LABORATORIES | 1.7% | 7.3% | 53.8% |
| DR REDDYS LABORATORIES | -1.9% | 4.5% | -9% |
| CIPLA | 1.5% | 5.5% | 19.6% |
| GLAND PHARMA | -1.6% | 2.6% | NA |
| PIRAMAL ENTERPRISES | 5.6% | 6.6% | 95.6% |
| TORRENT PHARMACEUTICALS | 0.2% | 1.5% | 7.4% |
| ALKEM LABORATORIES | 5.7% | 4.8% | 38.4% |
| Revenues | |
|---|---|
| Q-o-Q | 4.65 % |
| Y-o-Y | 14.53 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Jun2021 | ₹4,025 Cr | 4.65 | |
| Mar2021 | ₹3,847 Cr | 1.35 | |
| Dec2020 | ₹3,796 Cr | -0.64 | |
| Sep2020 | ₹3,820 Cr | 8.69 | |
| Jun2020 | ₹3,515 Cr | -6.33 | |
| Mar2020 | ₹3,752 Cr | 3.13 | |
| Dec2019 | ₹3,638 Cr | 8.06 | |
| Sep2019 | ₹3,367 Cr | - | |
| Operating Profit | |
|---|---|
| Q-o-Q | 9.08 % |
| Y-o-Y | 18.03 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Jun2021 | ₹933 Cr | 9.08 | |
| Mar2021 | ₹855 Cr | 6.00 | |
| Dec2020 | ₹807 Cr | -6.54 | |
| Sep2020 | ₹863 Cr | 9.22 | |
| Jun2020 | ₹791 Cr | -0.09 | |
| Mar2020 | ₹791 Cr | 13.38 | |
| Dec2019 | ₹698 Cr | 9.79 | |
| Sep2019 | ₹636 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 4.27 % |
| Y-o-Y | 3.07 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Jun2021 | 23.18% | 4.27 | |
| Mar2021 | 22.23% | 4.56 | |
| Dec2020 | 21.26% | -5.93 | |
| Sep2020 | 22.6% | 0.49 | |
| Jun2020 | 22.49% | 6.64 | |
| Mar2020 | 21.09% | 9.96 | |
| Dec2019 | 19.18% | 1.59 | |
| Sep2019 | 18.88% | - | |
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | -16.20 % |
| Y-o-Y | 34.95 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Jun2021 | ₹613 Cr | -16.20 | |
| Mar2021 | ₹732 Cr | 42.75 | |
| Dec2020 | ₹513 Cr | 20.99 | |
| Sep2020 | ₹424 Cr | -6.76 | |
| Jun2020 | ₹454 Cr | 9.87 | |
| Mar2020 | ₹414 Cr | 13.47 | |
| Dec2019 | ₹364 Cr | 339.57 | |
| Sep2019 | ₹83 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | -19.93 % |
| Y-o-Y | 17.79 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Jun2021 | 15.23 % | -19.93 | |
| Mar2021 | 19.02 % | 40.89 | |
| Dec2020 | 13.5 % | 21.73 | |
| Sep2020 | 11.09 % | -14.23 | |
| Jun2020 | 12.93 % | 17.33 | |
| Mar2020 | 11.02 % | 9.98 | |
| Dec2019 | 10.02 % | 307.32 | |
| Sep2019 | 2.46 % | - | |
| EPS | |
|---|---|
| Q-o-Q | -13.57 % |
| Y-o-Y | 29.35 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Jun2021 | ₹5.73 | -13.57 | |
| Mar2021 | ₹6.63 | 28.74 | |
| Dec2020 | ₹5.15 | 11.47 | |
| Sep2020 | ₹4.62 | 4.29 | |
| Jun2020 | ₹4.43 | 15.67 | |
| Mar2020 | ₹3.83 | 4.93 | |
| Dec2019 | ₹3.65 | 247.62 | |
| Sep2019 | ₹1.05 | - | |
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE DIVIDEND STABILITY | 3% | 7.3% | 49.6% |
| S&P BSE MOMENTUM | 2.8% | 7.2% | 41.8% |
| S&P BSE LARGECAP | 2.5% | 7.3% | 54.6% |
| S&P BSE LARGE MIDCAP | 2.5% | 7.6% | 56.6% |
| S&P BSE 250 LARGEMIDCAP | 2.5% | 7.6% | 57.8% |
| S&P BSE 200 | 2.5% | 7.6% | 57.5% |
| S&P BSE 100 LARGECAP TMC | 2.5% | 7.4% | 55.3% |
| S&P BSE 500 | 2.5% | 7.7% | 59.1% |
| S&P BSE ALLCAP | 2.4% | 7.7% | 60.1% |
| S&P BSE HEALTHCARE | 0.4% | 1.9% | 30.3% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY200 MOMENTUM 30 INDEX | 3.5% | 6.2% | NA |
| NIFTY 200 | 2.5% | 7.8% | 57.6% |
| NIFTY LARGE MIDCAP 250 | 2.5% | 8.3% | 63.2% |
| NIFTY 100 | 2.5% | 7.5% | 55.4% |
| NIFTY 500 | 2.5% | 7.8% | 59.1% |
| NIFTY500 MULTICAP 50:25:25 | 2.4% | 8.1% | NA |
| NIFTY 100 EQUAL WEIGHT | 2.2% | 7.9% | 63.1% |
| NIFTY ALPHA LOW-VOLATILTY 30 | 2.1% | 8.2% | 47.8% |
| NIFTY 100 ALPHA 30 | 1.8% | 6.6% | NA |
| NIFTY NEXT 50 | 1.7% | 8.3% | 57.7% |
| NIFTY PHARMA | 1.4% | 3.3% | 16.7% |
| NIFTY HEALTHCARE | 0.6% | 1.5% | NA |
#15A, 4th Floor, City Vista, Tower A,
Suite No.984, Fountain Road,
Kharadi, Pune - 411014
Contact Us
support@smart-investing.in
Smart-Investing.in
Pricing
Video Course
Blog
Tools
Screener
Compare
Analyze Portfolio
© 2019 - 2021 Smart-Investing.in. All rights reserved. Built with ❤️ in India
Disclaimer
The information on this site is for educational purposes only and is not investment/trading advice/research and may be delayed.
We don't make any Buy/Sell recommendations and don't give any price targets.
This tool provides statistical summaries of financial data in easy to understand visual form for informational purpose only.
Please do your own research before making any investment decisions.
Equity investments are volatile and high risk in nature. Don't invest more than what you can afford to lose. Past Performance is not indicative of future returns.
We have affiliate relationships with Amazon and Zerodha.
Financial Data Source: Accord Fintech |
Methodology |
Privacy Policy |
Terms & Conditions |
SEBI Registered Research Analyst Registration No : INH000007377 |
Disclosure